Table 1. Total costs, available funding and funding gaps in the Global Plan to Stop TB 2006–2015, as compared with the first Global Plan, 2001–2005.
Global Plan to Stop TB
(10-year plan)a |
First Global Plan
(5-year plan) |
||||
---|---|---|---|---|---|
Costs | Available funding | Funding gap | Costs | ||
Total implementation | 47.2 | 22.5 | 24.7 | 8.0 | |
Country costs | 44.3 | 21.8b | 22.5 | – | |
DOTS expansion | 28.9 | – | – | 6.0 | |
Strategy for multidrug-resistant tuberculosis | 5.8 | – | – | 1.1 | |
TB/HIV collaborative activities | 6.7 | – | – | 0.6 | |
Advocacy, communication and social mobilization programmes | 2.9 | – | – | 0.0 | |
International agencies (technical cooperation)c | 2.9 | 0.7 | 2.2 | 0.3 | |
Total new tools | 9.0 | 2.8 | 6.1 | 0.9 | |
Vaccinesd | 3.6 | 2.1 | 1.5 | 0.4 | |
Drugs | 4.8 | 0.6 | 4.2 | 0.3 | |
Diagnostics |
0.5 |
0.1 |
0.4 |
0.2 |
|
Total costs | 56.2 | 25.3 | 30.8 | 9.1 |
a All amounts shown in billions of US$. Column totals may not add up exactly due to rounding. b The figures for domestic funding assume that governments’ commitments in 2005 are sustained and increase in line with inflation; commitments from the Global Fund to Fight AIDS, Tuberculosis and Malaria are based on results. c Technical cooperation includes strategic and technical support, capacity building, monitoring and evaluation, operational research, policy development and working groups. d This category includes costs for maintenance of the current BCG (bacille Calmette–Guérin) vaccination programme.